Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A MAajor RAdiation-based PCI Study in STEMI and NSTEMI

NCT: NCT06565793 · ACTIVE_NOT_RECRUITING

NCT IDNCT06565793
StatusACTIVE_NOT_RECRUITING
Start Date2025-03-01
Completion2028-12-31
SponsorCentre Cardiologique du Nord (OTHER)
First posted
Last updated

Brief Summary

In France and Italy, approximately 240,000 percutaneous coronary angioplasties (PCI) are performed annually, with an increasing number of complex procedures, including those involving the left coronary common trunk, a bifurcation, chronic occlusion, or requiring Rotablator Rotary Atherectomy (ARota). The medical literature lacks sufficient data regarding several key aspects of complex angioplasty. These include the epidemiological characteristics of patients undergoing such procedures, the impact of irradiation delivered and the quantity of iodine injected on these lengthy procedures, their procedural complication rate, and in-hospital mortality.

Frequently Asked Questions

What is A MAajor RAdiation-based PCI Study in STEMI and NSTEMI?

A MAajor RAdiation-based PCI Study in STEMI and NSTEMI is a clinical trial registered under NCT06565793. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06565793?

The current status of NCT06565793 (A MAajor RAdiation-based PCI Study in STEMI and NSTEMI) is: ACTIVE_NOT_RECRUITING.

When did A MAajor RAdiation-based PCI Study in STEMI and NSTEMI start?

A MAajor RAdiation-based PCI Study in STEMI and NSTEMI started on 2025-03-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.